Deferoxamine

• Target :

  Antioxidant|||Apoptosis|||Reactive Oxygen Species|||Akt|||HIF/HIF Prolyl-Hydroxylase|||Autophagy|||ROS|||HIF

• Related Pathways :

  NF-?B|||Autophagy|||Oxidation-Reduction|||Immunology/Inflammation|||PI3K/Akt/mTOR signaling|||Angiogenesis|||Chromatin/Epigenetic|||Cytoskeletal Signaling|||Metabolism|||Apoptosis

• Purity :

  0.9997

• Bioactivity :

  Deferoxamine (Desferrioxamine B) is an iron chelator. Deferoxamine can be used to reduce the accumulation and deposition of iron in tissues. Deferoxamine can improve neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. It has antioxidant, anti-proliferation and anti-tumor activities, and can induce the production of HIF-1?, apoptosis and autophagy in cancer cells. It can be used to treat acute iron toxicity and COVID-19 related diseases.

• Smiles :

  O=C(NCCCCCN(O)C(=O)C)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN

• Molecular Formula :

  C25H48N6O8

• Molecular Weight :

  560.68

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  70-51-9